Retigabine – a new antiepileptic drug with a different mechanism of action
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0
Abstract
Retigabine belongs to a new generation of antiepileptic drugs. Its mechanism of action is different from that previously known. Retigabine opens potassium channels of subfamily Kv 7, especially Kv 7.2 and Kv 7.3. The drug enhances GABA-ergic transmission. It is well absorbed from the digestive system and undergoes metabolism via glucuronidation and acetylation. There is no interaction between retigabine and other antiepileptic drugs except lamotrigine. The drug has been registered as treatment of partial onset seizures with or without secondary generalization in adults. The efficacy of retigabine is being tested in other types of seizures and disorders characterized by neuronal hyperexcitability. Neuroprotective activity of retigabine is also being researched.
Authors and Affiliations
Ewa Zwierzyńska, Bogusława Pietrzak
Keywords
Related Articles
- EP ID EP67115
- DOI -
- Views 162
- Downloads 0
The maintenance of genetic stability of embryonic and induced pluripotent stem cells during anticancer therapies
Regenerative medicine is a very rapidly developing discipline. Its progress contributes to elongated life expectancy and improved quality of life of patients suffering from so far incurable diseases. Stem cells (SCs) are...
Nitroksydy jako antyoksydanty – możliwości ich zastosowania w celach chemioprewencyjnych oraz radioprotekcyjnych
Nitroksydy jako trwałe rodniki organiczne początkowo wykorzystywane były jako znaczniki spinowe w spektroskopii elektronowego rezonansu paramagnetycznego (electron paramagnetic resonance – EPR) w badaniach takich param...
Nowotworowe naczynia krwionośne
Wzrost nowotworu uzależniony jest od własnego unaczynienia. Małe, awaskularne nowotwory (1–2 mm3) nie mogą się rozwijać dopóki w środowisku nowotworowym nie nastąpi załamanie równowagi między czynnikami proangiogennymi...
Novel PKD1 mutations – the effect on clinical phenotype of ADPKD patients in Lower Silesia
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development and progressive enlargement of cysts in the kidneys. The diagnosis of ADPKD is usually determined by criteria of rena...
Angiotensin (1-7): A new link in the renin-angiotensin-aldosterone system (RAAS)
The discovery of a new angiotensin-converting enzyme (ACE2) and studies of the biological activity of angiotensin (1-7) indicate the complexity of the functioning of the renin-angiotensin-aldosterone system (RAAS). In th...